GPT and steatosis: It is important to note that the studies examining the treatment effect in NAFLD are heterogeneous, relating to variability in inclusion criteria (simple steatosis through to NASH and cirrhosis) as well as primary outcomes that range from normalisation of ALT or improvement on MRS (magnetic resonance spectroscopy) of hepatic fat through to histological improvement.